4.6 Article

Impaired CD4 T Cell Memory Response to Streptococcus pneumoniae Precedes CD4 T Cell Depletion in HIV-Infected Malawian Adults

期刊

PLOS ONE
卷 6, 期 9, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0025610

关键词

-

资金

  1. Wellcome Trust (United Kingdom) [083603/A/07/Z, 084679/Z/08/Z]
  2. Commonwealth Scholarship Commission (United Kingdom) [MWCS-2007-477]
  3. Wellcome Trust [084679/Z/08/Z, 083603/A/07/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

Objective: Invasive pneumococcal disease (IPD) is a leading cause of morbidity and mortality in HIV-infected African adults. CD4 T cell depletion may partially explain this high disease burden but those with relatively preserved T cell numbers are still at increased risk of IPD. This study evaluated the extent of pneumococcal-specific T cell memory dysfunction in asymptomatic HIV infection early on in the evolution of the disease. Methods: Peripheral blood mononuclear cells were isolated from asymptomatic HIV-infected and HIV-uninfected Malawian adults and stained to characterize the underlying degree of CD4 T cell immune activation, senescence and regulation. Pneumococcal-specific T cell proliferation, IFN-gamma, IL-17 production and CD154 expression was assessed using flow cytometry and ELISpot. Results: We find that in asymptomatic HIV-infected Malawian adults, there is considerable immune disruption with an increase in activated and senescent CD4(+) CD38(+) PD-1(+) and CD4(+) CD25(high)Foxp3(+) Treg cells. In the context of high pneumococcal exposure and therefore immune stimulation, show a failure in pneumococcal-specific memory T cell proliferation, skewing of T cell cytokine production with preservation of interleukin-17 but decreased interferon-gamma responses, and failure of activated T cells to express the co-stimulatory molecule CD154. Conclusion: Asymptomatic HIV-infected Malawian adults show early signs of pneumococcal-specific immune dysregulation with a shift in the balance of CD4 memory, T helper 17 cells and Treg. Together these data offer a mechanistic understanding of how antigen-specific T cell dysfunction occurs prior to T cell depletion and may explain the early susceptibility to IPD in those with relatively preserved CD4 T cell numbers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Hepatitis B Vaccination Impact and the Unmet Need for Antiviral Treatment in Blantyre, Malawi

Alexander J. Stockdale, James E. Meiring, Isaac T. Shawa, Deus Thindwa, Niza M. Silungwe, Maurice Mbewe, Rabson Kachala, Benno Kreuels, Pratiksha Patel, Priyanka Patel, Marc Y. R. Henrion, Naor Bar-Zeev, Todd D. Swarthout, Robert S. Heyderman, Stephen B. Gordon, Anna Maria Geretti, Melita A. Gordon

Summary: A study conducted in Blantyre, Malawi found that infant HBV vaccination has been highly effective in reducing HBsAg prevalence in adults, but some HBsAg-positive adults have an unmet need for antiviral therapy.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Medicine, Research & Experimental

Differential localization and limited cytotoxic potential of duodenal CD8+Tcells

Leonard Mvaya, Trevor Khaba, Agness E. Lakudzala, Thandeka Nkosi, Ndaru Jambo, Innocent Kadwala, Anstead Kankwatira, Priyanka D. Patel, Melita A. Gordon, Tonney S. Nyirenda, Kondwani C. Jambo, Zaza M. Ndhlovu

Summary: The duodenum serves as a major site of HIV persistence during suppressive antiretroviral therapy, with tissue-resident memory (Trm) CD8+ T cells playing a significant role. HIV-specific CD8+ Trm cells in the duodenum are enriched and exhibit high polyfunctionality but lack expression of canonical cytolytic molecules. These findings shed light on the mechanisms of HIV persistence in the duodenum and have implications for cure therapies.

JCI INSIGHT (2022)

Article Medicine, General & Internal

The COVID-19 pandemic in the African continent

Godfrey Bwire, Alex Riolexus Ario, Patricia Eyu, Felix Ocom, Joseph F. Wamala, Kwadwo A. Kusi, Latif Ndeketa, Kondwani C. Jambo, Rhoda K. Wanyenze, Ambrose O. Talisuna

Summary: This passage introduces the discovery of a new coronavirus and the associated COVID-19 disease in China in December 2019. It explains that scientists initially predicted a severe situation in Africa, but the reality did not match the predictions. Therefore, the purpose of this forum is to bring together experts to discuss the current situation of COVID-19 in Africa, analyze why Africa's situation differs from the predictions, and propose measures to support Africa in overcoming the negative effects of COVID-19 and accelerate the achievement of sustainable development goals.

BMC MEDICINE (2022)

Article Medicine, General & Internal

AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

Marah G. Chibwana, Thandeka Moyo-Gwete, Gaurav Kwatra, Jonathan Mandolo, Tandile Hermanaus, Thopisang Motlou, Nonkululeko Mzindle, Frances Ayres, Mphatso Chaponda, Godwin Tembo, Percy Mwenechanya, Ndaona Mitole, Chisomo Jassi, Raphael Kamng'ona, Louise Afran, David Mzinza, Henry C. Mwandumba, Stephen B. Gordon, Khuzwayo Jere, Shabir Madhi, Penny L. Moore, Robert S. Heyderman, Kondwani C. Jambo

Summary: This study aimed to assess the dynamics of anti-Spike antibodies in an African adult population with prior SARS-CoV-2 infection and determine the effect of subsequent COVID-19 vaccination. The findings showed that neutralizing antibodies wane within 6 months post-infection, but a single dose of the AstraZeneca COVID-19 vaccine significantly increased antibody levels. Furthermore, the antibodies generated after vaccination demonstrated broad cross-reactivity against multiple variants and had neutralizing potency.

BMC MEDICINE (2022)

Article Immunology

High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis

Andrew D. McCallum, Henry E. Pertinez, Aaron P. Chirambo, Irene Sheha, Madalitso Chasweka, Rose Malamba, Doris Shani, Alex Chitani, Jane E. Mallewa, Jamilah Z. Meghji, Jehan F. Ghany, Elizabeth L. Corbett, Stephen B. Gordon, Geraint R. Davies, Saye H. Khoo, Derek J. Sloan, Henry C. Mwandumba

Summary: This study explores the relationship between intrapulmonary drug levels and sputum bacillary clearance in tuberculosis treatment. The results show that higher drug exposure to rifampicin or isoniazid in the epithelial lining fluid is associated with more rapid bacillary elimination. Higher doses of rifampicin and isoniazid may result in sustained high intrapulmonary drug exposure, rapid bacillary clearance, shorter treatment duration, and better treatment outcomes.

CLINICAL INFECTIOUS DISEASES (2022)

Article Public, Environmental & Occupational Health

A secondary data analysis of a cluster randomized controlled trial: improved cookstoves associated with reduction in incidence of low birthweight in rural Malawi

Rebecca Best, Jullita Mvala, Albert Dube, Cynthia Katundu, Fredrick Kalobekamo, Kevin Mortimer, Stephen B. Gordon, Moffat Nyirenda, Amelia Crampin, Estelle McLean

Summary: This study provides evidence that an improved cookstove intervention in rural Malawi may reduce the number of babies born with low birthweight. This finding is supported by additional subset analysis. The intervention appears to decrease the number of infants born prematurely or with intra-uterine growth restriction, indicating that improved cookstoves could be a beneficial maternal health intervention.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2022)

Article Immunology

Defective Monocyte Enzymatic Function and an Inhibitory Immune Phenotype in Human Immunodeficiency Virus-Exposed Uninfected African Infants in the Era of Antiretroviral Therapy

Louise Afran, Kondwani C. Jambo, Wilfred Nedi, David J. C. Miles, Anmol Kiran, Dominic H. Banda, Ralph Kamg'ona, Dumizulu Tembo, Annette Pachnio, Eleni Nastouli, Brigit Ferne, Henry C. Mwandumba, Paul Moss, David Goldblatt, Sarah Rowland-Jones, Adam Finn, Robert S. Heyderman

Summary: The study found that HEU infants have altered monocyte function and B-cell subset homeostasis compared to HU infants, as well as lower vaccine-induced antibody responses to Haemophilus influenzae type b and tetanus toxoid. Additionally, human herpes virus infection rates were similar between HEU and HU infants.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Critical Care Medicine

Human Infection Challenge with Serotype 3 Pneumococcus

Ryan E. Robinson, Elena Mitsi, Elissavet Nikolaou, Sherin Pojar, Tao Chen, Jesus Reine, Tinashe K. Nyazika, James Court, Kelly Davies, Madlen Farrar, Partricia Gonzalez-Dias, Josh Hamilton, Helen Hill, Lisa Hitchins, Ashleigh Howard, Angela Hyder-Wright, Maia Lesosky, Konstantinos Liatsikos, Agnes Matope, Daniella McLenaghan, Christopher Myerscough, Annabel Murphy, Carla Solorzano, Duolao Wang, Hassan Burhan, Manish Gautam, Elizabeth Begier, Christian Theilacker, Rohini Beavon, Annaliesa S. Anderson, Bradford D. Gessner, Stephen B. Gordon, Andrea M. Collins, Daniela M. Ferreira

Summary: This study evaluated the colonization ability and safety of Streptococcus pneumoniae serotype 3 (SPN3) in the nasopharynx using a human challenge model. The results showed that colonization rates varied with inoculum doses and isolate types, and colonization may cause mild upper respiratory symptoms.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Immunology

Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study

Marianne Koenraads, Todd D. Swarthout, Naor Bar-Zeev, Comfort Brown, Jacquline Msefula, Brigitte Denis, Queen Dube, Stephen B. Gordon, Robert S. Heyderman, Melissa J. Gladstone, Neil French

Summary: This study examined the burden of invasive pneumococcal disease (IPD) in infants <90 days old in Blantyre, Malawi over a 14-year period and evaluated the impact of the pneumococcal conjugate vaccine (PCV13) on vaccine-serotype IPD in this population. The results showed that vaccine serotypes 1 and 5 were the main cause of IPD in neonates and young infants, both before and after PCV13 introduction.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

Article Medicine, General & Internal

Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi

Upendo L. Mseka, Jonathan Mandolo, Kenneth Nyoni, Oscar Divala, Dzinkambani Kambalame, Daniel Mapemba, Moses Kamzati, Innocent Chibwe, Marc Y. R. Henrion, Kingsley Manda, Deus Thindwa, Memory Mvula, Bright Odala, Raphael Kamng'ona, Nelson Dzinza, Khuzwayo C. Jere, Nicholas Feasey, Antonia Ho, Abena S. Amoah, Melita Gordon, Todd D. Swarthout, Amelia Crampin, Robert S. Heyderman, Matthew Kagoli, Evelyn Chitsa-Banda, Collins Mitambo, John Phuka, Benson Chilima, Watipaso Kasambara, Kondwani C. Jambo, Annie Chauma-Mwale

Summary: A study conducted in Malawi found that the seroprevalence of SARS-CoV-2 antibodies is high among the population, but the COVID-19 vaccination coverage is low. Vaccinated individuals have higher levels of SARS-CoV-2 antibodies compared to the unvaccinated. Additionally, there was a reduction in hospitalizations and deaths during the Omicron variant wave in Malawi.

ECLINICALMEDICINE (2023)

Article Infectious Diseases

A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study

Catherine Anscombe, Samantha Lissauer, Herbert Thole, Jamie Rylance, Dingase Dula, Mavis Menyere, Belson Kutambe, Charlotte van der Veer, Tamara Phiri, Ndaziona Banda, Kwazizira Mndolo, Kelvin Mponda, Chimota Phiri, Jane Mallewa, Mulinda Nyirenda, Grace Katha, Henry Mwandumba, Stephen B. Gordon, Kondwani C. Jambo, Jennifer Cornick, Nicholas Feasey, Kayla G. Barnes, Ben Morton, Philip M. Ashton

Summary: This study explores the relationship between viral lineage and patient outcome in COVID-19. By observing and sequencing patients in Blantyre, Malawi, it was found that each wave of patients was infected with a different viral variant. The clinical data suggests that patients with severe COVID-19 were more likely to die during the Delta wave.

BMC INFECTIOUS DISEASES (2023)

Article Multidisciplinary Sciences

Optimal age targeting for pneumococcal vaccination in older adults; a modelling study

Deus Thindwa, Samuel Clifford, Jackie Kleynhans, Anne von Gottberg, Sibongile Walaza, Susan Meiring, Todd D. Swarthout, Elizabeth Miller, Peter McIntyre, Nick Andrews, Zahin Amin-Chowdhury, Norman Fry, Kondwani C. Jambo, Neil French, Samanta Cristine Grassi Almeida, Shamez N. Ladhani, Robert S. Heyderman, Cheryl Cohen, Maria Cristina de Cunto Brandileone, Stefan Flasche

Summary: The risk of invasive pneumococcal disease (IPD) increases with age for older adults, but the population benefiting from pneumococcal vaccines and the immunogenic response to vaccination decline. This study examined the impact of demographics, vaccine efficacy, and waning efficacy on the optimal age for pneumococcal vaccination. The findings suggest that administering pneumococcal vaccines earlier in adulthood in low/middle-income countries could prevent a significant proportion of residual IPD burden.

NATURE COMMUNICATIONS (2023)

Article Infectious Diseases

Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage of Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a randomised controlled trial and controlled human infection study

Dingase Dula, Ben Morton, Tarsizio Chikaonda, Anthony E. Chirwa, Edna Nsomba, Vitumbiko Nkhoma, Clara Ngoliwa, Simon Sichone, Bridgette Galafa, Godwin Tembo, Mphatso Chaponda, Neema Toto, Raphael Kamng'ona, Lumbani Makhaza, Alfred Muyaya, Faith Thole, Evaristar Kudowa, Ashleigh Howard, Tinashe Kenny-Nyazika, John Ndaferankhande, Christopher Mkandawire, Gift Chiwala, Lorensio Chimgoneko, Ndaziona P. K. Banda, Jamie Rylance, Daniela Ferreira, Kondwani Jambo, Marc Y. R. Henrion

Summary: This study aimed to assess the efficacy of the 13-valent pneumococcal conjugate vaccine (PCV13) against pneumococcal carriage. The results showed that the vaccine group had a significantly lower carriage rate compared to the placebo group, with an estimated efficacy of 62.4%. This study provides important evidence for establishing vaccine-induced correlates of protection and comparing alternative strategies to prevent pneumococcal carriage.

LANCET MICROBE (2023)

Article Immunology

SARS-CoV-2 Prevalence in Malawi Based on Data from Survey of Communities and Health Workers in 5 High-Burden Districts, October 2020

Joe Alex Theu, Alinune Nathanael Kabaghe, George Bello, Evelyn Chitsa-Banda, Matthews Kagoli, Andrew Auld, Jonathan Mkungudza, Gabrielle O'Malley, Fred Fredrick Bangara, Elizabeth F. Peacocke, Yusuf Babaye, Wingston Ng'ambi, Christel Saussier, Ellen MacLachlan, Gertrude Chapotera, Mphatso Dennis Phiri, Evelyn Kim, Mabvuto Chiwaula, Danielle Payne, Nellie Wadonda-Kabondo, Annie Chauma-Mwale, Titus Henry Divala

Summary: This study conducted a multistage cluster survey in 5 districts of Malawi to determine the early burden of COVID-19, finding infection prevalence and seroprevalence among both community members and health facility staff. Most of the infected participants were asymptomatic, with higher seroprevalence in urban areas. The cumulative infection findings were significantly higher compared to national statistics, highlighting the importance of identifying alternative surveillance approaches and predictors of severe disease.

EMERGING INFECTIOUS DISEASES (2022)

暂无数据